Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2005 1
2006 2
2007 2
2008 3
2009 2
2011 2
2012 6
2013 10
2014 7
2015 2
2016 7
2017 7
2018 7
2019 12
2020 15
2021 15
2022 9
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Nutritional Aspects in Inflammatory Bowel Diseases.
Balestrieri P, Ribolsi M, Guarino MPL, Emerenziani S, Altomare A, Cicala M. Balestrieri P, et al. Among authors: cicala m. Nutrients. 2020 Jan 31;12(2):372. doi: 10.3390/nu12020372. Nutrients. 2020. PMID: 32023881 Free PMC article. Review.
Psychological distress in inflammatory bowel disease.
Balestrieri P, Cicala M, Ribolsi M. Balestrieri P, et al. Among authors: cicala m. Expert Rev Gastroenterol Hepatol. 2023 Jan-Jun;17(6):539-553. doi: 10.1080/17474124.2023.2209723. Epub 2023 May 30. Expert Rev Gastroenterol Hepatol. 2023. PMID: 37254523 Review.
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.
Peyrin-Biroulet L, Allegretti JR, Rubin DT, Bressler B, Germinaro M, Huang KG, Shipitofsky N, Zhang H, Wilson R, Han C, Feagan BG, Sandborn WJ, Panés J, Hisamatsu T, Lichtenstein GR, Sands BE, Dignass A; QUASAR Study Group. Peyrin-Biroulet L, et al. Gastroenterology. 2023 Dec;165(6):1443-1457. doi: 10.1053/j.gastro.2023.08.038. Epub 2023 Sep 1. Gastroenterology. 2023. PMID: 37659673 Free article. Clinical Trial.
Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial.
Corazziari ES, Gasbarrini A, D'Alba L, D'Ovidio V, Riggio O, Passaretti S, Annibale B, Cicala M, Repici A, Bassotti G, Ciacci C, Di Sabatino A, Neri M, Bragazzi MC, Ribichini E, Radocchia G, Iovino P, Marazzato M, Schippa S, Badiali D. Corazziari ES, et al. Among authors: cicala m. Am J Gastroenterol. 2023 Nov 1;118(11):2014-2024. doi: 10.14309/ajg.0000000000002360. Epub 2023 Jun 13. Am J Gastroenterol. 2023. PMID: 37307528 Free PMC article. Clinical Trial.
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR; GALAXI-1 Study Group. Danese S, et al. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):133-146. doi: 10.1016/S2468-1253(23)00318-7. Epub 2023 Dec 14. Lancet Gastroenterol Hepatol. 2024. PMID: 38104569 Clinical Trial.
Achalasia, from diagnosis to treatment.
Ribolsi M, Andrisani G, Di Matteo FM, Cicala M. Ribolsi M, et al. Among authors: cicala m. Expert Rev Gastroenterol Hepatol. 2023 Jan;17(1):21-30. doi: 10.1080/17474124.2022.2163236. Epub 2023 Jan 1. Expert Rev Gastroenterol Hepatol. 2023. PMID: 36588469
Protective Role of Natural Compounds under Radiation-Induced Injury.
Altomare A, Fiore M, D'Ercole G, Imperia E, Nicolosi RM, Della Posta S, Pasqua G, Cicala M, De Gara L, Ramella S, Guarino MPL. Altomare A, et al. Among authors: cicala m. Nutrients. 2022 Dec 17;14(24):5374. doi: 10.3390/nu14245374. Nutrients. 2022. PMID: 36558533 Free PMC article. Review.
106 results